Oncologic diagnosis and treatment decisions based on molecular pathology findings are extremely complex. Issues include unknown mutations that require interpretation and decision making based on the latest medical knowledge, as well as a lack of suitable clinical decision platforms that support supraregional exchange and joint evaluation of molecular pathological findings.
navify Tumor Board enables secure and efficient collaboration between molecular pathologists, oncologists and other experts across institutions, regions and countries. Relevant patient data and assets are accessed on the secure platform, helping authorized experts make informed diagnosis and treatment decisions. Clinical decision support applications, such as navify Clinical Trial Match, provide clinical care teams with access to the most up-to-date medical knowledge.
navify Tumor Board standardizes and optimizes the communication, preparation, presentation and documentation processes of the MTB Norddeutschland. All external participants, independent of a small clinic or a teaching hospital, can easily create a patient case that includes all necessary information and outlines points of discussion. For each patient case, a dedicated key opinion leader meets virtually with a multidisciplinary team in different MTB rooms highlighting specific expertise in different types of cancer or in different regions.